Zurcher Kantonalbank (Zurich Cantonalbank) Spero Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$7.87 - $15.15 $10,042 - $19,331
-1,276 Reduced 39.55%
1,950 $17,000
Q4 2021

Feb 01, 2022
SELL
$13.09 - $18.77 $4,280 - $6,137
-327 Reduced 9.2%
3,226 $52,000
Q3 2021

Nov 15, 2021
BUY
$13.03 - $19.51 $1,224 - $1,833
94 Added 2.72%
3,553 $65,000
Q2 2021

Jul 30, 2021
BUY
$12.22 - $15.79 $2,004 - $2,589
164 Added 4.98%
3,459 $48,000
Q1 2021

May 03, 2021
BUY
$13.23 - $21.48 $43,592 - $70,776
3,295 New
3,295 $49,000

Others Institutions Holding SPRO

# of Institutions
49
Shares Held
13.9M
Call Options Held
200
Put Options Held
200
View Full List

About Spero Therapeutics, Inc.

SPRO Quotes by TradingView
  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $41.4M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email